Stem cells made available for API development by European biobank

A German biobank has made stem cells available to active pharmaceutical ingredient (API) firms this week in a bid to support industry drug development efforts. The Fraunhofer Institute for Biomedical Engineering (IBMT) in St. Ingbert, Germany and its …

[Read the full article here]

Comments are closed.